Centre for Outcomes Research & Evaluation, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Department of Medicine, Division of Gastroenterology, McGill University, Montréal, Québec, Canada.
PLoS One. 2021 Mar 18;16(3):e0248679. doi: 10.1371/journal.pone.0248679. eCollection 2021.
Mobile health (mHealth) technologies are innovative solutions for delivering instructions to patients preparing for colonoscopy.
To systematically review the literature evaluating the effectiveness of mHealth technologies supporting colonoscopy preparation on patient and clinical outcomes.
MEDLINE, EMBASE, CINAHL and CENTRAL were searched for randomized controlled trials (RCTs) that evaluated the effectiveness of mHealth technologies for colonoscopy preparation on patient and clinical outcomes. Two reviewers independently assessed study eligibility, extracted data, and appraised methodological quality using the Cochrane Risk-of-Bias tool. Data were pooled using random effects models and when heterogeneity, assessed using I2, was statistically significant, a qualitative synthesis of the data was performed. Publication bias was assessed using a funnel plot.
Ten RCTs (3,383 participants) met inclusion criteria. MHealth interventions included smartphone apps, SMS text messages, videos, camera apps, and a social media app. Outcomes were bowel cleanliness quality, user satisfaction, colonoscopy quality indicators (cecal intubation time, withdrawal time, adenoma detection rate), adherence to diet, and cancellation/no-show rates. MHealth interventions were associated with better bowel cleanliness scores on the Boston Bowel Preparation Scale [standardized mean difference (SMD) 0.57, 95%CI 0.37-0.77, I2 = 60%, p = 0.08] and the Ottawa Bowel Preparation Scale [SMD -0.39, 95%CI -0.59-0.19, I2 = 45%, p = 0.16], but they were not associated with rates of willingness to repeat the colonoscopy using the same regimen [odds ratio (OR) 1.88, 95%CI 0.85-4.15, I2 = 48%, p = 0.12] or cancellations/no-shows [OR 0.96, 95%CI 0.68-1.35, I2 = 0%]. Most studies showed that adequate bowel preparation, user satisfaction and adherence to diet were better in the intervention groups compared to the control groups, while inconsistent findings were observed for the colonoscopy quality indicators. All trials were at high risk of bias for lack of participant blinding. Visual inspection of a funnel plot revealed publication bias.
MHealth technologies show promise as a way to improve bowel cleanliness, but trials to date were of low methodological quality. High-quality research is required to understand the effectiveness of mHealth technologies on colonoscopy outcomes.
移动医疗(mHealth)技术是为准备结肠镜检查的患者提供指导的创新解决方案。
系统评价评估 mHealth 技术支持结肠镜检查准备对患者和临床结局影响的文献。
在 MEDLINE、EMBASE、CINAHL 和 CENTRAL 中搜索评估 mHealth 技术用于结肠镜检查准备对患者和临床结局影响的随机对照试验(RCT)。两位审查员独立评估研究的纳入标准,提取数据,并使用 Cochrane 偏倚风险工具评估方法学质量。使用随机效应模型对数据进行合并,当异质性用 I2 评估且存在统计学意义时,对数据进行定性综合。使用漏斗图评估发表偏倚。
符合纳入标准的 10 项 RCT(3383 名参与者)。mHealth 干预措施包括智能手机应用程序、短信、视频、相机应用程序和社交媒体应用程序。结局是肠清洁质量、用户满意度、结肠镜检查质量指标(盲肠插管时间、退出时间、腺瘤检出率)、饮食依从性和取消/失约率。mHealth 干预措施与波士顿肠道准备量表的肠清洁评分更高相关[标准化均数差(SMD)0.57,95%CI 0.37-0.77,I2 = 60%,p = 0.08]和渥太华肠道准备量表[SMD -0.39,95%CI -0.59-0.19,I2 = 45%,p = 0.16],但它们与使用相同方案再次进行结肠镜检查的意愿率无关[比值比(OR)1.88,95%CI 0.85-4.15,I2 = 48%,p = 0.12]或取消/失约率[OR 0.96,95%CI 0.68-1.35,I2 = 0%]。大多数研究表明,干预组的肠道准备充分、用户满意度和饮食依从性优于对照组,而结肠镜检查质量指标的结果不一致。所有试验因参与者缺乏盲法而存在高偏倚风险。漏斗图的直观检查显示存在发表偏倚。
mHealth 技术有望改善肠清洁度,但迄今为止的试验方法学质量较低。需要高质量的研究来了解 mHealth 技术对结肠镜检查结果的有效性。